Related Experiment Video
Updated: May 15, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Regulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in
Claire Regazzetti1, Karine Dumas, Yannick Le Marchand-Brustel
1INSERM U 1065, Mediterranean Research Centre for Molecular Medicine, Team: Cellular and Molecular Physiopathology of obesity and diabetes, Nice, France.
Abstract:
REDD1 (Regulated in development and DNA damage response 1) is a hypoxia and stress response gene and is a negative regulator of mTORC1. Since mTORC1 is involved in the negative feedback loop of insulin signaling, we have studied the role of REDD1 on insulin signaling pathway and its regulation by insulin. In human and murine adipocytes, insulin transiently stimulates REDD1 expression through a MEK dependent pathway. In HEK-293 cells, expression of a constitutive active form of MEK stabilizes REDD1 and protects REDD1 from proteasomal degradation mediated by CUL4A-DDB1 ubiquitin ligase complex. In 3T3-L1 adipocytes, silencing of REDD1 with siRNA induces an increase of mTORC1 activity as well as an inhibition of insulin signaling pathway and lipogenesis. Rapamycin, a mTORC1 inhibitor, restores the insulin signaling after downregulation of REDD1 expression. This observation suggests that REDD1 positively regulates insulin signaling through the inhibition of mTORC1 activity. In conclusion, our results demonstrate that insulin increases REDD1 expression, and that REDD1 participates in the biological response to insulin.
Insights
Regulated in development and DNA damage response 1 (REDD1) positively impacts insulin signaling. Insulin boosts REDD1 expression, which then inhibits mTORC1, enhancing the insulin pathway and lipogenesis.
Area of Science:
- Cellular biology
- Molecular endocrinology
- Metabolic signaling
Background:
- Regulated in development and DNA damage response 1 (REDD1) is a known hypoxia and stress response gene.
- REDD1 acts as a negative regulator of the mechanistic target of rapamycin complex 1 (mTORC1).
- mTORC1 plays a role in the negative feedback loop of insulin signaling.
Purpose of the Study:
- To investigate the role of REDD1 in the insulin signaling pathway.
- To determine how insulin regulates REDD1 expression and function.
Main Methods:
- Insulin stimulation assays in human and murine adipocytes and HEK-293 cells.
- MEK pathway analysis and manipulation.
- REDD1 silencing using siRNA in 3T3-L1 adipocytes.
- Assessment of mTORC1 activity and insulin signaling components.
- Proteasomal degradation studies involving CUL4A-DDB1 ubiquitin ligase complex.
Main Results:
- Insulin transiently stimulates REDD1 expression via a MEK-dependent pathway in adipocytes.
- Active MEK stabilizes REDD1, protecting it from proteasomal degradation.
- REDD1 downregulation increases mTORC1 activity and inhibits insulin signaling and lipogenesis.
- Rapamycin treatment restores insulin signaling following REDD1 downregulation.
Conclusions:
- REDD1 positively regulates insulin signaling by inhibiting mTORC1 activity.
- Insulin-induced REDD1 expression is a key component of the biological response to insulin.
- REDD1 acts as a crucial link between insulin stimulation and metabolic outcomes.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway

